To screen ETFs by asset class, performance, yield and more, check out the
Author Following Options:
Follow this author
See their articles on your Seeking Alpha homepage and in your feed.
Real-time alerts on this author
Get their new articles emailed to you as they are published.
Daily digest on all my authors
Get all your favorite authors’ new articles emailed to you in one daily digest.
View Ockham Research's Comments
Align Technologies Takes One in the Teeth
I must apologize for my misstatement. Clearly, I misunderstood something I read and believed that Orthoclear was still in operation. Thank you for the catch. I have corrected it on our blog and will contact our syndication partners to correct my mistake elsewhere.
In fact, you are correct about the lawsuit (
). What I read compared the potential growth for Dentsply's product based on the early adoption of Orthoclear's product (obviously before the lawsuit was settled). Again, I do apologize and I take responsibility for not fully investigating Orthoclear.
I can assure you that this was not an attempt at market manipulation. Neither myself nor Ockham Research as a firm have any financial position in this or any other stock that we write about.
Apr 6, 2010. 01:28 PM
Link to Comment
More on ALGN by Ockham Research
Xignite quote data
© 2014 Seeking Alpha